TAKING a common arthritis drug could be more effective than antidepressants in helping to cure depression, a study suggests.
UK scientists find tocilizumab, commonly used for rheumatoid arthritis, may help antidepressant-resistant patients ...
Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key ...
The anti-inflammatory drug tocilizumab targets the IL-6 pathway to achieve a 54% remission rate in hard-to-treat depression.
New hope for earlier treatment might be on the horizon for people suffering the most severe form of depression. In a study of patients watching emotionally evocative movies, the responses of people ...
Researchers investigated for the first time whether tocilizumab could improve symptoms of depression in people who have not ...
Earlier this week, the United States Food and Drug Administration (FDA) approved a human trial for a blueberry-sized brain implant intended to target treatment-resistant depression. The brain-computer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results